Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.
Tomas BlazekZuzana Zděblová ČermákováLukas KnybelPavel HurníkJan ŠtembírekKamila ResováTereza ParačkováMartin FormánekJakub CvekRenata SoumarováPublished in: Radiation oncology (London, England) (2021)
The combination of EBRT and stereotactic hypofractionated boost is safe and seems to be an effective option for dose escalation in patients with advanced floor of the mouth tumors who are ineligible for surgical treatment and require a non-invasive approach.